Health Care & Life Sciences » Biotechnology | RespireRx Pharmaceuticals Inc.

RespireRx Pharmaceuticals Inc.

RespireRx Pharmaceuticals Inc.
Stock Exchange Other OTC
EPS
$0.68
Market Cap
$3.29 M
Shares Outstanding
3.87 M
Public Float
1.67 M

Profile

Address
126 Valley Road
Glen Rock New Jersey 07452
United States
Employees -
Website http://www.respirerx.com
Updated 07/08/2019
RespireRx Pharmaceuticals, Inc. engages in the discovery, development and commercialization of innovative pharmaceuticals for the treatment of neurological and psychiatric disorders. It focuses on clinical development in the area of respiratory disorders, particularly sleep apneas and respiratory depression produced by drugs and neural damage, which provides the opportunities for development and commercialization of its compounds. The company was founded by Carl W.

Financials

View All
Created with Highcharts 5.0.14RespireRx Pharmaceuticals Inc.Net Income. Fiscal year is January-December. All values USD Thousands.1 2011 2012 7072 7075 9615 9619 2299 2294 2914 2912 5912 59120132014201520162017201802.5k5k7.5k10k
Created with Highcharts 5.0.14RespireRx Pharmaceuticals Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.006161868600002 1762 17620132014201520162017201805001000150020002500

Arnold S. Lippa
Executive Chairman & Chief Scientific Officer
James S. J. Manuso
Vice Chairman, President & Chief Executive Officer